DAX-1 is an unusual member of the nuclear hormone receptor superfamily whose expression is mainly, but not uniquely, restricted to steroidogenic tissues. We have recently shown that DAX-1 can block the first and rate-limiting step in steroid biosynthesis by repressing StAR (steroidogenic acute regulatory protein) expression. Here we show that DAX-1 blocks steroid production at multiple levels in the Y-1 mouse adrenocortical tumor cell line. Expression of DAX-1 in Y-1 cells significantly impairs both basal and cAMP-stimulated steroid production, without affecting the functionality of the cAMPresponsive PKA pathway. Experiments using an hydroxylated cholesterol derivative show that biochemical steps in steroidogenesis subsequent to cholesterol delivery to mitochondria are also impaired in Y-1 cells expressing DAX-1. This is explained by the repression of P450scc and 3␤-HSD expression, in addition to StAR. DAX-1 expression in Y-1 cells results in the inhibition of the activity of the StAR, P450scc and 3␤-HSD promoters. An inappropriate steroidogenic block in the male fetus might have an important role in the pathogenesis of sex reversal syndromes caused by a duplication of the genomic region of the X chromosome containing the DAX-1 gene. (Endocrinology 139: [4237][4238][4239][4240][4241][4242][4243] 1998) 
S
TEROID hormone production in the fasciculata portion of the adrenal cortex is regulated by the pituitary hormone corticotropin (ACTH) through the cAMP signal transduction pathway (1, 2) . The role of orphan members of the nuclear receptor superfamily in mediating transcriptional regulation of several steroid hydroxylase genes has been elucidated (3) (4) (5) . In particular, steroidogenic factor-1 (SF-1) (6, 7) has been shown to play a pivotal role in adrenal cortex morphogenesis and function. SF-1 positively regulates the expression of multiple cytochrome P450 steroid hydroxylases by binding to specific DNA sequences present in their promoters (8) . In addition, SF-1 regulates the expression of the steroidogenic acute regulatory protein (StAR) (9, 10) . StAR has been demonstrated to be essential for the ratelimiting step in steroid biosynthesis, the transfer of cholesterol to the inner mitochondrial membrane (11, 12) . Here P450scc can convert it into pregnenolone, and this compound can then be further transformed into progesterone by 3␤-HSD (13) .
DAX-1 is an unusual member of the nuclear receptor superfamily (14) whose expression is mostly restricted to steroidogenic tissues (adrenal cortex, ovary, Leydig cells) (15, 16) . In addition, DAX-1 is also expressed in testicular Sertoli cells, pituitary gonadotropes and in the ventromedial hypothalamic nucleus (15, 16) . Mutations in the DAX-1 gene cause adrenal hypoplasia congenita (AHC), which is usually associated with hypogonadotropic hypogonadism (HHG) (14, 17) . AHC is an X-linked disorder characterized by impaired development of the permanent zone of the adrenal cortex. After birth, only large vacuolated cells resembling fetal adrenocortical cells are present in the adrenal cortex of patients with AHC. This results in adrenal insufficiency early in infancy, with low serum concentration of glucocorticoids, mineralocorticoids and androgens, and failure to respond to ACTH stimulation (14, 17) . HHG is diagnosed at the expected time of pubertal maturation in AHC patients treated with steroids and is caused by a selective defect in gonadotropins production, with all other pituitary hormones being normal (14, 17) . It has been shown that both a deficit of GnRH release from the hypothalamus and pituitary impairment of LH and FSH secretion contribute to the pathogenesis of HHG in patients with AHC (18) . In addition, the DAX-1 gene locus is situated in Xp21, within the critical interval delimited for the DSS (dosage-sensitive sex reversal) region (19) . Male patients with a duplication of the DSS region develop as phenotypic females (19) . We have recently shown that DAX-1 acts as a negative regulator of steroid production in adrenal cells by repressing the expression of StAR. DAX-1 inhibition of StAR expression is dependent upon binding to a hairpin DNA site in the StAR gene promoter (20) .
Here we report that DAX-1 can affect the steroidogenic cascade at multiple levels in Y-1 adrenocortical cells, inhibiting the expression of enzymes involved in different steps of this process.
Materials and Methods

Cell culture
The Y-1 mouse tumor adrenocortical cell line was obtained from ATCC and maintained in DMEM/Ham's F-10 1:1 medium (Sigma Chemical Co., St. Louis, MO), supplemented with 15% horse serum and 2.5% FCS.
Transfections
To obtain stably transfected cell lines, Y-1 cells were transfected by the calcium phosphate technique with pD383, which carries the neomycin resistance gene (20) , alone (Y-1/neo) or in a 1:10 ratio together with pSG.DAX-1 (14) (Y-1/hDAX-1) or MT-REV(AB) neo (21; Y-1/RI AB ). Clones were selected and maintained in medium containing 500 g/ml G418 (Gibco BRL, Gaithersburg, MD).
For For PKA pathway studies, Y-1 clones were transfected with 1 g of a CAT reporter plasmid (p4xCRE CAT) containing a tetramerized cAMP-responsive element (TGACGTCA) and a basal HSV thymidine kinase promoter.
CAT and luciferase assays were performed using standard techniques (14, 20) , and results were normalized for ␤-galactosidase activity. Each experiment was performed at least three times in duplicate.
Assay for secreted steroids
Three hundred thousand cells seeded onto 60-mm plates were cultured in regular medium plus G418 for 24 h, and then in DMEM/Ham's F-10 1:1 containing 1.5% FCS for an additional 24 h. Fresh medium containing either forskolin (Sigma; 10 g/ml) or ethanol vehicle was then added, and incubation was continued for an additional 16 h. Supernatants were then harvested for fluorogenic steroid measurement, as described (25, 26) . This sensitive assay detects 20-and 21-hydroxylated steroids (25) . These steroids have the property to be highly fluorescent, with an excitation peak at 470 nm and an emission peak at 536 nm, when they are in a solution of sulfuric acid in ethanol (25) . For the assay, 0.3 ml of culture medium were centrifuged and extracted with 0.7 ml of methylene chloride. The organic phase was extracted with 0.7 ml of 65% sulfuric acid in ethanol for 1 min and then 0.5 ml of the acid were transferred into a glass tube containing 3 ml of 65% sulfuric acid in ethanol. After 90 min, sample fluorescence was measured using a Hitachi F-2000 fluorescence spectrophotometer, with an excitation wavelength of 470 nm and an emission wavelength of 536 nm. Corticosterone (Sigma) was used as a standard. The total amount of steroids measured was then normalized to the cellular protein content of secreting cells. Each measurement was the average of triplicate cultures, and six independent experiments were performed. The mean intraassay coefficient of variation for three distinct samples assayed in 12 sets of triplicates was 5.1; mean interassay coefficient of variation for the same samples run in 10 separate assays in triplicate was 11.1.
For assay of pregnenolone and progesterone, 5 ϫ 10 4 Y-1/neo, Y-1/ hDAX-1 and Y-1/RI AB cells/well were seeded in triplicate in a 96-well culture plate and cultured overnight in serum-containing medium. Cells were washed twice with serum-free medium and then incubated for 2 h in serum-free medium in basal conditions or stimulated with forskolin (10 g/ml), with and without 25 m 22(R)-hydroxycholesterol (Sigma). Pregnenolone and progesterone in the supernatants were measured by a specific RIA, as described (11) .
PKA assay
PKA activity was determined as described previously (26) . Briefly, 10 l of cell extract (at a concentration of 2 mg/ml) were added to a 40-l reaction mix containing a final concentration of 20 mm Tris-HCl (pH 7.4), 10 mm magnesium acetate, 0.5 mm IBMX (Sigma), 10 
Northern and Western blot
Northern and Western analyses were performed as previously described (20) . Anti DAX-1 2F4 mouse monoclonal antibody (15) and anti-StAR rabbit polyclonal antiserum (11) were used for detection of the DAX-1 and StAR proteins, respectively. Antisera directed against P450scc and 3␤-HSD were kindly provided by G. Defaye (INSERM U244, CENG, Grenoble, France) (27) .
Statistical analysis
The Wilcoxon rank sum test was used to assess the statistical significance of differences in steroid production (both in basal conditions and after forskolin stimulation) between Y-1/neo cells and Y-1/hDAX-1 clones. A value of P Ͻ 0.05 was considered as statistically significant.
Results
Steroid production is impaired in Y-1 cells expressing DAX-1
Y-1 mouse adrenocortical tumor cells have been widely used to study the biochemical mechanisms of steroid hormone production in the adrenal gland (28) . These cells do not express DAX-1 (Fig. 1A) , and therefore they constitute a convenient system to study the effect of DAX-1 expression on differentiated adrenocortical cell function. To this purpose, we have produced stably transfected Y-1 clones that express the human DAX-1 complementary DNA under the control of the SV40 early promoter (Y-1/hDAX-1). We also established cell lines expressing either the neomycin resistance gene (Y-1/neo) or a cAMP-dependent protein kinase type I␣ regulatory subunit (RI␣) harboring mutations in both sites A and B of the cAMP-binding domain (Y-1/RI AB ). Expression of this mutated RI␣ has been previously shown to markedly impair steroidogenesis in Y-1 cells (21) .
Although clonal variability in steroid production is known to occur in Y-1 cells (28), a remarkable homogeneity exists in seven independent Y-1/hDAX-1 clones, all of which express approximately the same amount of DAX-1 protein (Fig. 1A) . All Y-1/hDAX-1 clones produce very low levels of fluorogenic steroids, both in basal conditions and after stimulation of the cAMP pathway by forskolin (overall mean (Ϯsem) 3.49 Ϯ 0.4 g/mg cell protein in basal conditions; 5.09 Ϯ 0.42 g/mg cell protein, forskolin-stimulated) (Fig. 1B) . Conversely, Y-1/neo cells produce significantly higher amounts of steroids than Y-1/hDAX-1 cells (overall mean (Ϯsem) 6.19 Ϯ 1.6 g/mg cell protein in basal conditions; 36.4 Ϯ 19 g/mg cell protein, forskolin-stimulated). (Fig. 1B) . Y-1/ hDAX-1 cells steroidogenic capacity is more severely impaired after forskolin stimulation (about 6.5 fold; P Ͻ 0.025) than in basal conditions (about 2-fold; P Ͻ 0.05), compared with Y-1/neo cells. Given their homogeneous phenotype, one of the Y-1/hDAX-1 clones was chosen at random for further characterization.
The PKA pathway is functional in Y-1/hDAX-1 cells
Because steroid production in adrenal cells is known to be regulated by the cAMP pathway (2, 13), the DAX-1 effect could be due to an impairment in the transduction of the cAMP signal. We measured PKA activity in Y-1/hDAX-1 cells and found that it is comparable to Y-1/neo cells ( Fig.  2A) . Conversely, and consistent with previous results (21, 26) , PKA activity is reduced in the Y-1/RI AB cells, which express a dominant-negative RI␣ (Fig. 2A) . In addition, Y-1/ DAX-1 cells assume the characteristic round shape after forskolin stimulation (not shown). This phenomenon has been shown to require a functional PKA (2). Finally, forskolinstimulated expression of a CRE (cAMP responsive element) reporter plasmid, which is activated by cAMP-responsive factors of the CREB/CREM/ATF family, is not impaired in Y-1 DAX-1 cells (Fig. 2B) . Taken all together, these results show that the cAMP-dependent signaling pathway remains functional in Y-1/hDAX-1 cells. In addition, expression of SF-1, which has been shown to be a critical regulator of the expression of StAR and of several enzymes involved in steroid biosynthesis (8) , is not impaired in Y-1/hDAX-1 cells (Fig. 2C) . SF-1 levels were not affected by forskolin stimulation in any of the cell lines (not shown).
Steroid production is impaired at multiple levels in Y-1/ hDAX-1 cells
To better define the level at which DAX-1 blocks steroidogenesis, we measured the production of pregnenolone and progesterone in the Y-1 derived cell lines, both in basal conditions and after a 2-h stimulation by forskolin. Y-1/neo cells produce only a small amount of pregnenolone, which is converted rapidly into progesterone, indicating the presence of active 3␤-HSD in these cells (Fig. 3, histograms 1-4) . Conversely, production of both pregnenolone and progesterone is extremely low in Y-1/hDAX-1 and in Y-1/RI AB cells (Fig.  3, histograms 9 -12/17-20) .
22(R)-hydroxycholesterol is a cholesterol analog that is more accessible to the inner mitochondrial membrane, due to its higher solubility in water (29) . Only when 25 m 22(R)-hydroxycholesterol was added to the culture medium of Y-1/hDAX-1 cells could a small amount of pregnenolone be detected. In these cells, however, pregnenolone was not converted into progesterone, indicating that active 3␤-HSD is absent (Fig. 3, histograms 13-16 ). This pattern of steroid secretion closely resembles that of Y-1/RI AB cells, in which pregnenolone production was only marginally increased by 22(R)-hydroxycholesterol (Fig. 3, histograms 21-24 ). These data indicate that a nearly complete block exists in Y-1/ hDAX-1 cells in the first steps of the steroidogenic cascade.
Expression of StAR, P450scc and 3␤-HSD is impaired in Y-1 cells expressing DAX-1
To unveil the molecular basis of the steroidogenic block produced by DAX-1, we studied the expression of StAR, P450scc, and 3␤-HSD in Y-1/hDAX-1 cells. As we have reported earlier (20) , StAR RNA and protein are undetectable in Y-1/hDAX-1 cells and cannot be induced by forskolin treatment. Moreover, P450scc expression is also reduced by several fold when compared with Y-1/neo cells (Fig. 4, B and  C) . In addition, no 3␤-HSD expression can be detected (Fig.  4, B and C) . The impairment of the expression of these components of the steroidogenic machinery in Y-1/hDAX-1 cells accounts for their pattern of steroid production after administration of 22(R)-hydroxycholesterol and indicates that DAX-1 affects steroid synthesis by repressing multiple biochemical steps in the cascade.
Effect of DAX-1 on the activity of the StAR, P450scc and 3␤-HSD promoters
Recently we have shown that DAX-1 can repress the expression of the StAR promoter (20) . In light of the results presented above, we felt it was important to investigate whether the P450scc and 3␤-HSD promoters can be regulated by DAX-1 in a manner similar to StAR. In transiently transfected Y-1 cells DAX-1 represses basal and forskolin-induced activity of the P450scc promoter, as well as the StAR promoter, as previously shown (Fig. 5, A (Fig. 5C) . Conversely, stimulation of the cAMP pathway is unable to activate this promoter in Y-1/hDAX-1 cells (Fig. 5F ). These results show that DAX-1 expression in Y-1 cells can inhibit expression of StAR, P450scc and 3␤-HSD at the level of transcription.
Discussion
In the present study, we have shown that DAX-1 inhibits steroidogenesis at multiple levels in the Y-1 adrenocortical cell line. We have recently reported that DAX-1 blocks StAR expression and thus impairs the first and rate-limiting step in the steroidogenic cascade (20) . Here we have demonstrated, using the hydroxylated cholesterol analog 22(R)-hydroxycholesterol, that the steroidogenic block by DAX-1 is more profound in Y-1 cells, and also involves the impairment of the expression of the P450scc and 3␤-HSD enzymes. Thus, DAX-1 can inhibit StAR and P450scc at the level of gene expression. Conversely, we were unable to detect a significant effect of DAX-1 on the activity of the 3␤-HSD promoter in transiently transfected Y-1 cells, both in basal conditions and after forskolin stimulation. The stimulation of this promoter by cAMP, however, is blocked in Y-1/hDAX-1 cells. It might be possible that the impairment of steroid production at a very early stage in Y-1/hDAX-1 cells is responsible for down-regulation of 3␤-HSD expression. The function of this enzyme, in fact, is to convert pregnenolone into progesterone, and one could hypothesize that its presence is not needed if available substrates are lacking. Further studies are necessary to clarify this point.
The role of DAX-1 as a regulator of multiple steps in the steroidogenic cascade has interesting implications concerning the pathogenesis of the DSS syndrome. This syndrome is caused by a duplication of a genomic region situated in Xp21. Male subjects with a duplication of the DSS region are phenotypic females, even if a large spectrum of secondary sex characteristics is found in these patients (19) . Because the DAX-1 gene locus resides inside the critical region mapped for the DSS locus (14) , it is tempting to speculate that double dosage expression of DAX-1 could be responsible for sex reversal, because of an inappropriate suppression of sex steroid production by the male fetus.
The cAMP signal transduction pathway plays an essential role in eliciting steroid hormone biosynthesis in steroidogenic tissues (1, 2, 13) . It has been demonstrated that a functional cAMP-dependent PKA protein kinase is required for steroid production in adrenal cortical cells. Some Y-1 cell clones harbor point mutations in the regulatory subunit of type I PKA. These mutations render the enzyme resistant to activation by cAMP and impair steroidogenesis in these cells (2, 30) . Steroid production is also impaired in wild-type Y-1 cells transfected with a dominant-negative PKA regulatory subunit mutated in both the A and B sites of the cAMPbinding domain (21, and our data). Interestingly, both basal and cAMP-stimulated steroid production are down-regulated in these cells. This indicates that a basal level of activation of the cAMP pathway is also essential to sustain basal expression of the genes involved in the steroidogenic process (21) . Y-1/hDAX-1 cells are strikingly similar to Y-1 cells expressing a mutated PKA RI regulatory subunit because both their basal and cAMP-stimulated steroid production are impaired. Conversely, the functionality of the cAMP pathway is not affected by DAX-1 expression in Y-1 cells: both PKA activity and the capacity of nuclear factors to respond to the stimulation of the cAMP pathway are not affected in Y-1/hDAX-1 cells (see Fig. 2 ). A variety of agents and conditions are known to antagonize the cAMP pathway in steroidogenic cells and decrease steroid biosynthesis, such as heat shock (31), apoE expression (32), lipopolysaccharide (33) , phorbol esters (34), tumor necrosis factor-␣ (35), and PGF 2␣ (36) . It is possible that at least some of these agents might function either by inducing DAX-1 expression or by activating its function to repress the StAR and the P450scc promoters in steroidogenic cells.
The transcription factor SF-1 and its bovine homologue Ad4BP belong to the nuclear hormone receptor superfamily and are both related to Drosophila FTZ/F1, an orphan nuclear receptor that regulates the expression of the fushi tarazu homeobox gene (6, 7) . SF-1 has been shown to regulate the expression of multiple genes involved in the steroidogenic pathway (see Ref. 8 for review). It has been reported that SF-1 can mediate the cAMP-dependent transcriptional activation of P450scc, P450c17 and P450aro (37) (38) (39) . In addition, inactivation of the FTZ/F1 gene in the mouse causes the complete absence of adrenal glands and gonads (40) . Interestingly, there is full overlap between the sites of expression of the SF-1 and the DAX-1 genes (15, 16) . We (20) and others (41) have shown that DAX-1 can repress SF-1 mediated transactivation. This has raised the possibility that the two proteins could heterodimerize in solution (41). We have not been able to detect in vivo association of SF-1 and DAX-1 (unpublished observations). Instead, we have found that DAX-1 binds to hairpin DNA structures and that their deletion abrogates DAX-1 capacity to repress transactivation by SF-1 (20) . To explain the SF-1/DAX-1 functional interactions, we favor a model that envisages that DAX-1 binding to DNA results in down-regulation of SF-1-mediated transactivation by recruitment of the transcriptional silencing domain residing in the DAX-1 C-terminus (42) .
